Parsons TL[au] - Search Results

Year	Number of Results
1999	1
2004	1
2005	1
2006	4
2007	5
2008	5
2009	2
2010	5
2011	3
2012	5
2013	4
2014	6
2015	1
2016	3
2017	2
2018	5
2019	3
2020	4
2021	3
2023	3
2024	2

1

Large effects and the infinitesimal model.

Parsons TL, Ralph PL. Parsons TL, et al. Theor Popul Biol. 2024 Apr;156:117-129. doi: 10.1016/j.tpb.2024.02.009. Epub 2024 Feb 27. Theor Popul Biol. 2024. PMID: 38423480 Free article.

2

Evolutionary consequences of behavioral diversity.

Stewart AJ, Parsons TL, Plotkin JB. Stewart AJ, et al. Among authors: parsons tl. Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E7003-E7009. doi: 10.1073/pnas.1608990113. Epub 2016 Oct 24. Proc Natl Acad Sci U S A. 2016. PMID: 27791109 Free PMC article.

3

Exercise and end-stage kidney disease: functional exercise capacity and cardiovascular outcomes.

Parsons TL, King-Vanvlack CE. Parsons TL, et al. Adv Chronic Kidney Dis. 2009 Nov;16(6):459-81. doi: 10.1053/j.ackd.2009.08.009. Adv Chronic Kidney Dis. 2009. PMID: 19801136 Review.

4

Rates of SARS-CoV-2 transmission between and into California state prisons.

Dubey P, Hoover CM, Lu P, Blumberg S, Porco TC, Parsons TL, Worden L. Dubey P, et al. Among authors: parsons tl. medRxiv [Preprint]. 2023 Aug 25:2023.08.24.23294583. doi: 10.1101/2023.08.24.23294583. medRxiv. 2023. PMID: 37662306 Free PMC article. Preprint.

5

Interspecies Differences in Tenofovir Alafenamide Fumarate Stability in Plasma.

Parsons TL, Gwenden KN, Marzinke MA. Parsons TL, et al. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00930-20. doi: 10.1128/AAC.00930-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32540983 Free PMC article.

6

Mutational robustness can facilitate adaptation.

Draghi JA, Parsons TL, Wagner GP, Plotkin JB. Draghi JA, et al. Among authors: parsons tl. Nature. 2010 Jan 21;463(7279):353-5. doi: 10.1038/nature08694. Nature. 2010. PMID: 20090752 Free PMC article.

7

Assessing the risk of cascading COVID-19 outbreaks from prison-to-prison transfers.

Parsons TL, Worden L. Parsons TL, et al. Epidemics. 2021 Dec;37:100532. doi: 10.1016/j.epidem.2021.100532. Epub 2021 Nov 25. Epidemics. 2021. PMID: 34861580 Free PMC article.

8

Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide.

Cerrone M, Alfarisi O, Neary M, Marzinke MA, Parsons TL, Owen A, Maartens G, Pozniak A, Flexner C, Boffito M. Cerrone M, et al. Among authors: parsons tl. J Antimicrob Chemother. 2019 Jun 1;74(6):1670-1678. doi: 10.1093/jac/dkz068. J Antimicrob Chemother. 2019. PMID: 30815689 Free PMC article. Clinical Trial.

9

Effects of ritonavir-boosted lopinavir on the pharmacokinetics of quinine.

Nyunt MM, Lu Y, El-Gasim M, Parsons TL, Petty BG, Hendrix CW. Nyunt MM, et al. Among authors: parsons tl. Clin Pharmacol Ther. 2012 May;91(5):889-95. doi: 10.1038/clpt.2011.326. Clin Pharmacol Ther. 2012. PMID: 22472986 Clinical Trial.

10

Reconciling molecular phylogenies with the fossil record.

Morlon H, Parsons TL, Plotkin JB. Morlon H, et al. Among authors: parsons tl. Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16327-32. doi: 10.1073/pnas.1102543108. Epub 2011 Sep 19. Proc Natl Acad Sci U S A. 2011. PMID: 21930899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year